Indian Letrozole Exporters: Complete Supplier Ranking with Market Share — 252 Manufacturers (2026) — TransData Nexus

Q: Who is the largest letrozole supplier from India?

CIPLA LIMITED is the largest letrozole exporter from India with a 51.4% market share and export value of $16.5M.

Q: How many letrozole suppliers are there in India?

There are 252 active letrozole exporters in India, collectively shipping $32.1M worth of letrozole across 2,112 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top letrozole suppliers from India?

The top 5 letrozole suppliers from India — CIPLA LIMITED, INTAS PHARMACEUTICALS LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, EUGIA PHARMA SPECIALITIES LIMITED, ZYDUS LIFESCIENCES LIMITED — together control 88.5% of total letrozole export value from India.

Suresh Sormare

Letrozole

India Pharmaceutical Trade Intelligence

$32.1M252 Suppliers117 CountriesHS 30049049

ExportsIndia → THAILAND48.3%India → UNITED STATES12.1%

ImportsSWITZERLAND → India$30.9K BELGIUM → India$7.4K

#1 Supplier: CIPLA LIMITED

Letrozole Suppliers from India (2026) — 252 Exporters, $32.1M Market | TransData Nexus | TransData Nexus

Who Exports Letrozole from India — 252 Suppliers Behind a $32.1M Market

India's letrozole export market is supplied by 252 active exporters who collectively shipped $32.1M across 2,112 shipments. CIPLA LIMITED leads with a 51.4% market share, followed by INTAS PHARMACEUTICALS LIMITED and SUN PHARMACEUTICAL INDUSTRIES LIMITED. The top 5 suppliers together control 88.5% of total export value, reflecting a concentrated market structure.

Source: Indian Customs (DGFT)·Published March 2026

India's Top Letrozole Suppliers & Exporters — 252 manufacturers, $32.1M export market, top destinations and formulations — Letrozole supplier data — 252 exporters · $32.1M market · 2,112 shipmentsTransData Nexus · Indian Customs Data

Top Letrozole Exporters from India — Ranked by Export Value

CIPLA LIMITED is the leading letrozole exporter from India, holding a 51.4% share of the $32.1M market across 2,112 shipments from 252 exporters. The top 5 suppliers — CIPLA LIMITED, INTAS PHARMACEUTICALS LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, EUGIA PHARMA SPECIALITIES LIMITED, ZYDUS LIFESCIENCES LIMITED — collectively control 88.5% of total export value, indicating a highly concentrated market. Individual shares are: CIPLA LIMITED (51.4%), INTAS PHARMACEUTICALS LIMITED (21.6%), SUN PHARMACEUTICAL INDUSTRIES LIMITED (7.6%), EUGIA PHARMA SPECIALITIES LIMITED (5.7%), ZYDUS LIFESCIENCES LIMITED (2.3%).

Top Letrozole Exporters from India

Ranked by export value · 252 active suppliers · Indian Customs (DGFT) data

Mar 2026

Top Letrozole Exporters from India — Ranked by Export Value. 252 active suppliers with export value, shipments, countries and formulations data compiled from Indian Customs records by TransData Nexus.
#	Supplier & Formulations	Value	Ships.	Ctry.	Share
1

Letrozole — Export Intelligence Video

Visual overview of India's letrozole supplier landscape — top suppliers, destinations, pricing, and trade routes

This video covers India's letrozole pharmaceutical supplier landscape — $32.1M in total trade, 252 verified manufacturers. Data sourced from Indian Customs (DGFT) shipment records.

Supplier Certification & Compliance Matrix

FDA, WHO-GMP, and EU GMP status for top Letrozole exporters

Certification and compliance status for top Letrozole suppliers from India
Supplier	US FDA	WHO-GMP	EU GMP	ANDAs	Notes
CIPLA LIMITED	Approved	Yes	Yes	89	Cipla has received FDA approvals and holds WHO-GMP and EU GMP certifications.
INTAS PHARMACEUTICALS LIMITED	Approved	Yes	Yes	89	Intas has FDA approvals and WHO-GMP and EU GMP certifications; received FDA warn
SUN PHARMACEUTICAL INDUSTRIES LIMITED	Approved	Yes	Yes	89	Sun Pharma holds FDA approvals and WHO-GMP and EU GMP certifications.
ZYDUS LIFESCIENCES LIMITED	Approved	Yes	Yes	89	Zydus Lifesciences has FDA approvals and WHO-GMP and EU GMP certifications.
CADILA HEALTHCARE LIMITED	Approved	Yes	Yes	89	Cadila Healthcare holds FDA approvals and WHO-GMP and EU GMP certifications.
NATCO PHARMA LIMITED	Approved	Yes	Yes	89	Natco Pharma has FDA approvals and WHO-GMP and EU GMP certifications.
HETERO LABS LIMITED	Approved	Yes	Yes	89	Hetero Labs holds FDA approvals and WHO-GMP and EU GMP certifications.
NAPROD LIFE SCIENCES PRIVATE LIMITED	Approved	Yes	Yes	89	Naprod Life Sciences has FDA approvals and WHO-GMP and EU GMP certifications.

TransData Nexus reviewed the regulatory standing of 8 leading Letrozole exporters from India. 8 hold US FDA facility approvals, 8 maintain WHO-GMP certification, and 8 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.

Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.

TransData Nexus Research · Mar 2026

Manufacturing Hub Analysis — Vendor Proximity

India's pharmaceutical clusters relevant to Letrozole sourcing

1Hyderabad — Bulk Drug Capital

Hyderabad, often referred to as the "Bulk Drug Capital of India," contributes over 40% of the country's bulk drug production. This prominence is supported by a robust infrastructure that includes numerous bulk drug manufacturers and a skilled workforce. The city's pharmaceutical landscape is further enhanced by the presence of the Hyderabad Pharma City, a project recognized as a National Investment Manufacturing Zone (NIMZ) and a Project of National Importance by the Government of India in December 2019. This initiative aims to bolster the bulk drug manufacturing capabilities of the region, making Hyderabad a pivotal hub for active pharmaceutical ingredients (APIs) like Letrozole.

2Ahmedabad-Vadodara — Formulations Hub

The Ahmedabad-Vadodara corridor in Gujarat is renowned for its focus on pharmaceutical formulations. Vadodara, in particular, hosts numerous pharmaceutical companies specializing in the production of finished dosage forms. The region's pharmaceutical sector is characterized by a strong emphasis on research and development, leading to the production of high-quality formulations. This specialization positions the Ahmedabad-Vadodara cluster as a key player in the formulation and export of drugs like Letrozole.

3Mumbai-Thane-Raigad — Export Gateway

Recent M&A, Collaborations & Capacity Expansions

Industry developments among top Letrozole exporters from India

March 2025

M&A

Sun Pharmaceutical Industries Limited — Sun Pharma acquires Checkpoint Therapeutics for $355 million

In March 2025, Sun Pharma announced the acquisition of Checkpoint Therapeutics, a Waltham, Massachusetts-based company specializing in immunotherapy and targeted oncology treatments, for $355 million. IMPACT: This acquisition is expected to enhance Sun Pharma's oncology portfolio, potentially increasing its market share in cancer treatments, including Letrozole.

Impact: This acquisition is expected to enhance Sun Pharma's oncology portfolio, potentially increasing its market share in cancer treatments, including Letrozole.

June 2025

M&A

Zydus Lifesciences Limited — Zydus acquires Agenus' CDMO business and partners on molecule commercialization

In June 2025, Zydus Lifesciences acquired the contract development and manufacturing organization (CDMO) business of Agenus, including two biologics manufacturing sites in Emeryville and Berkeley. Additionally, Zydus partnered with Agenus to commercialize their molecules in India. IMPACT: This acquisition may bolster Zydus' manufacturing capabilities and product offerings, potentially affecting its Letrozole production and export capacity.

Impact: This acquisition may bolster Zydus' manufacturing capabilities and product offerings, potentially affecting its Letrozole production and export capacity.

Common Questions — Letrozole Suppliers from India

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

Q Which letrozole supplier from India is the most reliable for bulk orders?

Based on shipment frequency and export consistency, CIPLA LIMITED leads with 82 recorded shipments worth $16.5M. INTAS PHARMACEUTICALS LIMITED (493 shipments) and SUN PHARMACEUTICAL INDUSTRIES LIMITED (56 shipments) are also established high-volume exporters.

Q How many letrozole manufacturers are there in India?

India has 252 active letrozole exporters with a combined export market of $32.1M across 2,112 shipments to 117 countries. The top 5 suppliers hold 88.5% of total export value.

Q What certifications should I verify?

Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).

Q What is the typical price range for letrozole from India?

Average FOB unit price: $1.43 per unit, ranging from $0.00 to $141.64. Average shipment value: $15.2K.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Letrozole

Letrozole

Who Exports Letrozole from India — 252 Suppliers Behind a $32.1M Market

Top Letrozole Exporters from India — Ranked by Export Value

Top Letrozole Exporters from India

Related Analysis

Need Details?

Letrozole — Export Intelligence Video

Supplier Certification & Compliance Matrix

Manufacturing Hub Analysis — Vendor Proximity

1Hyderabad — Bulk Drug Capital

2Ahmedabad-Vadodara — Formulations Hub

3Mumbai-Thane-Raigad — Export Gateway

Recent M&A, Collaborations & Capacity Expansions

Sun Pharmaceutical Industries Limited — Sun Pharma acquires Checkpoint Therapeutics for $355 million

Zydus Lifesciences Limited — Zydus acquires Agenus' CDMO business and partners on molecule commercialization

Common Questions — Letrozole Suppliers from India

Q Which letrozole supplier from India is the most reliable for bulk orders?

Q How many letrozole manufacturers are there in India?

Q What certifications should I verify?

Q What is the typical price range for letrozole from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

4Baddi-Nalagarh — Tax Incentive Zone

5Sourcing Recommendations

Cipla Limited — Cipla acquires Ivia Beaute's cosmetics and personal care business for ₹130 crore

Analysis Methodology